Welcome to the e-CCO Library!

P064: TOP1210 narrow spectrum kinase inhibitor demonstrates superior activity and improved safety profile potential compared with corticosteroid and immunomodulators in preclinical models of colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. A. Walshe*, A. Rowley, M. R. Foster, Y. Solanke, S. Sirohi, 
M. C. Fyfe, S. Webber

Created: Friday, 22 February 2019, 9:49 AM
P065 Metabolic utilisation of propanediol by adherent-invasive E. coli regulates intestinal tissue immunity
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Viladomiu1, M. Metz1, S. Lima1, C.J. Guo1, K. Simpson2, E. Scherl1, R. Longman1

Created: Thursday, 30 January 2020, 10:12 AM
P0650: Comparative study between Kono-S and latero-lateral isoperistaltic anastomosis in the treatment of terminal ileum Crohn's Disease patients: perioperative complications and short-term results.
Year: 2025
Source: ECCO'25
Authors: Colombox7x7x7 F.(1);Gattix7x7x7 F.(1)*;Lazzarinox7x7x7 M.(1);Guercix7x7x7 C.(1);Gridavillax7x7x7 D.(2);Maconix7x7x7 G.(2);Danellix7x7x7 P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0651: Evaluating tryptophan as a biomarker for treatment success in Inflammatory Bowel Disease patients undergoing therapy
Year: 2025
Source: ECCO'25
Authors: Maaßx7x7x7 C.(1)*;Hatemx7x7x7 Y.(2);Adenx7x7x7 K.(3);Marquardtx7x7x7 J.U.(2);Solbachx7x7x7 P.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0652: Norovirus Infection May Be Responsible For More Severe Flares of Ulcerative Colitis
Year: 2025
Source: ECCO'25
Authors: Gawron-Kiszkax7x7x7 M.(1)*;Nowakowska-Duławax7x7x7 E.(1);Boryczkax7x7x7 G.(1);Dylińska-Kalax7x7x7 K.(1);Modrzejewskix7x7x7 M.(1);Tłuczykontx7x7x7 M.(1);Iwanickix7x7x7 T.(2);Hartlebx7x7x7 M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0653: Patients with ileo-anal J-Pouch display alteredx7x7x7 higher pouch contractility than controls as measured with motility MRI.
Year: 2025
Source: ECCO'25
Authors: Bladx7x7x7 W.(1)*;Menysx7x7x7 A.(2);Westonx7x7x7 W.(3);Dennisx7x7x7 C.(3);Naimx7x7x7 I.(2);Taylorx7x7x7 S.A.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0654: Switching from intravenous to subcutaneous infliximab: physicians' practice and patients' satisfaction - Results from a nationwide transectional study.
Year: 2025
Source: ECCO'25
Authors: Hupéx7x7x7 M.(1)*;Lahariex7x7x7 D.(2);Wilsx7x7x7 P.(3);Uzzanx7x7x7 M.(4);Peyrin-Birouletx7x7x7 L.(5);Kirchgesnerx7x7x7 J.(6);Atanasiux7x7x7 C.(7);Cadiotx7x7x7 G.(8);Richardx7x7x7 N.(9);Simonx7x7x7 M.(10);Caillox7x7x7 L.(11);Nanceyx7x7x7 S.(12);de Maissinx7x7x7 A.(13);Vuittonx7x7x7 L.(14);Hébuternex7x7x7 X.(15);Alricx7x7x7 H.(16);Coffinx7x7x7 B.(17);Gellouzx7x7x7 S.(18);Buissonx7x7x7 A.(19);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0655: VTE thromboprophylaxis in patients with inflammatory bowel disease admitted to hospital; can we increase adherence with guidelines?
Year: 2025
Source: ECCO'25
Authors: Dasx7x7x7 A.(1)*;Florezx7x7x7 C.S.(1);Lesliex7x7x7 F.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0656: Adalimumab mono vs. combination therapy in Crohn's Disease: Real world experience
Year: 2025
Source: ECCO'25
Authors: Babicx7x7x7 F.(1)*;Cacicx7x7x7 P.(1);Biscaninx7x7x7 A.(1);Kraljx7x7x7 D.(1);Ogresta Kordejx7x7x7 D.(1);Dorosulicx7x7x7 Z.(1);Hrabarx7x7x7 D.(1);Tomasicx7x7x7 V.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0657: Quality of ileocolic resection in Crohn’s disease- A systemic review and meta-analysis
Year: 2025
Source: ECCO'25
Authors: Lingamx7x7x7 G.(1)*;De Burletx7x7x7 K.(1);Shakirx7x7x7 T.(2);Khattabx7x7x7 M.(3);Yiux7x7x7 A.(4);Giannaroux7x7x7 S.(5);Francisx7x7x7 N.(6x7x7x77);Sahnanx7x7x7 K.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0658: Comparison of the Efficacy and Safety of Immunomodulator Use in Geriatric and Non-Geriatric Patients with Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Arıx7x7x7 D.(1);Kenarlıx7x7x7 K.(1)*;Bacaksızx7x7x7 F.(2);Arıx7x7x7 S.(3);Gökbulutx7x7x7 V.(1);Öztürkx7x7x7 Ö.(1);Özderin Özinx7x7x7 Y.(1);Kalkanx7x7x7 İ.H.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0659: Exploring Ferric Maltol: A Promising Alternative to IV Iron for Managing Chronic Iron Deficiency Anaemia in Inflammatory Bowel Disease Patients
Year: 2025
Source: ECCO'25
Authors: Wongx7x7x7 F.(1)*;Kamperidisx7x7x7 N.(1);Angelax7x7x7 C.(1);Youngx7x7x7 L.(1);Tyrrellx7x7x7 T.(1);Passosx7x7x7 D.(1);Al-Zarradx7x7x7 D.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P065: Altered B cell expansion and maturation in Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kappel-Latif, S.(1);Kotagiri, P.(2);Schuld, G.(1);Schlager, L.(1);Walterskirchen, N.(1);Schimek, V.(1);Jobst, J.(1);Murthy, S.(3);Messner, B.(4);Lyons, P.A.(2);Oehler, R.(1);Bergmann, M.(1);Stift, A.(1);Unger, L.(5)*;
Created: Friday, 14 July 2023, 10:48 AM
P065: Conservation of breast milk cytokine profiles in consecutive pregnancies of women with inflammatory bowel disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Agrawal, M.(1);Tarassishin, L.(2);Rendon, A.(2);Debebe, A.(2);Hillenbrand, C.(2);White, S.(2);Eisele, C.(2);Hawkins, K.(2);Chen, C.L.(3);Kornbluth, A.(1);George, J.(1);Legnani, P.(1);Maser, E.(1);Stone, J.(4);Dubinsky, M.(5);Sabino, J.(1,6);Torres, J.(1,7);Colombel, J.F.(1);Peter, I.(2);Hu, J.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P065: Determination of the cytokine pattern of human colon organoids derived from Inflammatory Bowel Disease patients
Year: 2022
Source: ECCO'22
Authors: Molnár, T.(1,2);Jójárt, B.(1,2,3);Resál , T.(1);Szántó, K.(1);Kata, D.(4);Földesi, I.(4);Molnár, T.(1);Maléth, J.(1,2,3,5);Farkas, K.(1);
Created: Friday, 11 February 2022, 3:52 PM
P065: Effects of gut bacteria on the intestinal immune cell composition and barrier function
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Schmidt F.*1, Dahlke K.2, Batra A.1,3, Ring C.2, Keye J.1, Loh G.2,4, Schumann M.1, Kühl A.1, Blaut M.2, Siegmund B.1

Created: Wednesday, 20 February 2019, 10:36 AM
P065: Molecular landscape of early Crohn’s disease using an integrated approach of mRNA/miRNA profiling and genomics
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Verstockt*1, J. Van der Goten2, M. Vancamelbeke2, B. Verstockt2, F. Schuit3, P. Rutgeerts2, M. Ferrante2, S. Vermeire2, I. Arijs2, I. Cleynen1

Created: Friday, 22 February 2019, 9:49 AM
P065: Olfactory receptor, OR51E2 is a marker for innate immune cells in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. J. Lee*1, N. J. Kim1, S. B. Park1, J. S. Koo1, Y. T. Jeen1, J. J. Park1, M. K. Joo1

Created: Friday, 22 February 2019, 9:41 AM
P065: REDD1/autophagy-driven NETosis promotes IL-1β-mediated inflammation in active ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Chrysanthopoulou1, I. Angelidou1, A. Mitsios1, S. Arelaki2, A. Arampatzioglou1, K. Kambas1, D. Ritis1, V. Tsironidou1, I. Moschos3,4, I. Mitroulis5, G. Kouklakis3,4, P. Skendros1,3*

Created: Thursday, 21 February 2019, 9:14 AM
P066 Azathioprine linked with impaired intestinal epithelial regeneration in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Borycka-Kiciak1, A. Pietrzak2,3, K. Ferenc4, P. Pietrzak4,5, L. Janaszek1, W. Tarnowski1, R. Zabielski4

Created: Thursday, 30 January 2020, 10:12 AM